Cutler Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-570
Closed -$6K 4419
2022
Q3
$6K Buy
570
+230
+68% +$26K ﹤0.01% 3464
2022
Q2
$4K Buy
340
+195
+134% +$15.1K ﹤0.01% 3819
2022
Q1
$1K Buy
+145
New +$19.1K ﹤0.01% 4897
2021
Q4
Sell
-131
Closed -$1K 5388
2021
Q3
$1K Buy
+131
New +$37.4K ﹤0.01% 5233
2021
Q2
Sell
-46
Closed -$1K 5699
2021
Q1
$1K Sell
46
-726
-94% -$357K ﹤0.01% 5139
2020
Q4
$1K Buy
+772
New +$489K ﹤0.01% 4375
2020
Q3
Sell
-1,004
Closed -$14K 4677
2020
Q2
$14K Hold
1,004
﹤0.01% 2616
2020
Q1
$10K Sell
1,004
-146
-13% -$142K ﹤0.01% 2704
2019
Q4
$63K Hold
1,150
﹤0.01% 1463
2019
Q3
$61K Buy
1,150
+772
+204% +$1.18M 0.01% 1390
2019
Q2
$19K Hold
378
﹤0.01% 2243
2019
Q1
$73K Sell
378
-386
-51% -$680K 0.01% 1187
2018
Q4
$222K Hold
764
0.02% 589
2018
Q3
$497K Sell
764
-548
-42% -$1.13M 0.03% 465
2018
Q2
$618K Buy
1,312
+154
+13% +$351K 0.05% 374
2018
Q1
$741K Sell
1,158
-865
-43% -$2.2M 0.06% 296
2017
Q4
$1.74M Sell
2,023
-7
-0.3% -$14.2K 0.07% 203
2017
Q3
$1.04M Sell
2,030
-1,652
-45% -$2.31M 0.04% 336
2017
Q2
$546K Buy
3,682
+1,590
+76% +$1.92M 0.02% 647
2017
Q1
$501K Sell
2,092
-3,050
-59% -$3.11M 0.02% 639
2016
Q4
$124K Sell
5,142
-15
-0.3% -$11.9K ﹤0.01% 1711
2016
Q3
$458K Buy
5,157
+3,351
+186% +$2.43M 0.02% 655
2016
Q2
$44K Sell
1,806
-170
-9% -$96.3K ﹤0.01% 2474
2016
Q1
$14K Sell
1,976
-1,274
-39% -$782K ﹤0.01% 3666
2015
Q4
$83K Buy
+3,250
New +$3.25M ﹤0.01% 1939

Other funds holding BLUE

Cutler Group's BLUE Position: Q1 2024 in Review

Cutler Group held its bluebird bio (BLUE) position steady in Q1 2024 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Cutler Group first reported a position in BLUE in Q4 2015 and has held it in 22 quarters since. The position peaked at $3.52M in Q4 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Cutler Group held 40 shares of bluebird bio worth $1K as of Q1 2024.
  • Cutler Group left its bluebird bio share count unchanged in Q1 2024.
  • bluebird bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1952 holding.
  • Cutler Group first reported a position in bluebird bio in Q4 2015 and has held it in 22 quarters since.
  • Cutler Group's bluebird bio position peaked at $3.52M in Q4 2015.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.